PRO/AH/EDR> COVID-19 update (06): breath antibodies, antibody duration, variant, WHO, global

COVID-19 — Israel
Israel based Scentech-Medical announced it had received approval from the Shamir Medical Center Review Board for a new clinical trial to demonstrate its ability to monitor the antibody levels and type of antibodies developed by the population of subjects getting vaccinated for the SARS-CoV-2 coronavirus. Scentech, which is merging with NextGen Biomed Ltd, reports that using the test developed for the analysis and quantification of volatile compounds in breath can detect coronavirus patients,